BioSpace News Archive

Business

Pharma Logistics Announces Partnership with Texas Association of Community Health Centers (TACHC)

Pharma Logistics is announcing a partnership with Texas Association of Community Health Centers (TACHC) to offer its reverse pharmaceutical distribution services.

August 27, 2018
·
1 min read
Pharm Country

UPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business

Conference call for investors at 8:00 a.m. (Eastern Time) on Thursday, September 13th, to review its Pharmaceutical Business

August 27, 2018
·
1 min read
Policy

Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

Jazz Pharmaceuticals plc announced that the European Commission approved Vyxeos® 44 mg/100 mg powder for concentrate for solution for infusion for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia

August 27, 2018
·
8 min read
New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia

Masimo announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, Belgium

August 27, 2018
·
8 min read
Policy

Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

Novasep is proud to announce that its API development and manufacturing site in Chasse-sur-Rhone, France, has been successfully inspected by the US Food and Drug Administration (FDA)

August 27, 2018
·
1 min read
Business

Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development

Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development.

August 27, 2018
·
2 min read
Pharm Country

Applied DNA Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit

High-Expression Amplicons Facilitate Non-Recombinant Gene Therapies. Hold the Potential to Serve as an Alternative to Plasmids and Viral Vectors.

August 27, 2018
·
5 min read
Drug Development

Janssen Announces Results from MARINER and COMMANDER HF Studies

Company sees a filing pathway for approval in acute medically ill

August 27, 2018
·
22 min read
Drug Development

Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018

ATTR-ACT Showed that Tafamidis Significantly Reduced the Combination of All-cause Mortality and Cardiovascular-related Hospitalizations

August 27, 2018
·
9 min read
Business

MarketsandMarkets and SRI International Announce Strategic Innovation Collaboration

Industry and technology analysis together with deep research capabilities offer clients enhanced market insights

August 27, 2018
·
3 min read